STVN

NYSE Stevanato Group SpA
Nov 22, 2026 · 2:05 AM ET EOD Market Closed

$15.65 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.65, $0.50 below the day’s high of $16.15

YTD change
-22.22%
vs 20-day SMA
-3.85%
vs 200-day SMA
-12.67%

Price ranges

Previous day
$15.35 $16.15
open $15.90 close $15.65
-$0.25 (-1.57%)
Today
$15.35 $16.15
$15.65
Past week
$14.36 $16.09
from $14.36 now $15.65
+$1.29 (+8.98%)
Past month
$12.05 $20.80
from $19.50 now $15.65
-$3.85 (-19.74%)
This year
$12.05 $23.25
from $20.12 now $15.65
-$4.47 (-22.22%)

Price & Performance

-2.20 (-12.32%) / 6M

$12.45$16.12$19.79$23.46May 21Aug 21Nov 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 56.9% away from all-time highs of $36.30
  • STVN is down 22% since the beginning of the year
  • STVN is down 26% over the past 12 months
  • STVN is down 20% over the past 1 month
  • 2% of all STVN investors are betting against STVN
  • Number of investors short STVN has gone down 19% versus last month

STVN reads neutral: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -30.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.179112
Earnings momentum +18.2% Quarterly EPS growth
Quarterly change +18.2%

Valuation

P/E ratio 27.04
Enterprise value $4.8B
Beta 0.88

Balance sheet & scale

Income$156.8K
Revenue$1.4B
Cash$130.5M
Debt$532.7K
Income / Debt 0.29×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $777.9M

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CIBC CDR C REG S $34.42 +1.38%
BDX Becton, Dickinson and Company $212.78 +0.05%
MDLN Medline, Inc. Class A $37.04 -2.11%
DXCM DexCom, Inc. $79.32 -1.08%
WST West Pharmaceutical Services, Inc. $390.30 -1.61%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.